J. V. van Diessen

发表

The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial).

J. Sonke, W. V. van Elmpt, D. de Ruysscher, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab.

J. Aerts, E. Dieleman, M. Verheij, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Stage I non-small cell lung cancer: Treatment modalities, Dutch daily practice and future perspectives.

H. Klomp, A. D. de Langen, K. Hartemink, 2021, Cancer treatment and research communications.

Is pneumonectomy justifiable for patients with a locoregional recurrence or persistent disease after curative intent chemoradiotherapy for locally advanced non-small cell lung cancer?

E. Smit, H. Klomp, M. Dahele, 2020, Lung cancer.

Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas

E. van Werkhoven, M. Tesselaar, L. van der Velden, 2016, Cancers.

Current Treatment Options for Local Residual Nasopharyngeal Carcinoma

I. Tan, C. Leemans, B. Karakullukcu, 2013, Current Treatment Options in Oncology.

Differential analysis of local and regional failure in locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy.

J. Sonke, J. Belderbos, M. M. van den Heuvel, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced NSCLC patients.

J. Sonke, J. Belderbos, M. Kwint, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer—results from a retrospective analysis

J. W. Oosterhuis, E. Smit, H. Klomp, 2021, Interactive cardiovascular and thoracic surgery.

Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer

J. Schellens, M. Verheij, D. Pluim, 2020, Clinical Cancer Research.

18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): results from a randomised clinical trial.

J. Sonke, W. V. van Elmpt, K. Sikorska, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Heart dose associated with overall survival in locally advanced NSCLC patients treated with hypofractionated chemoradiotherapy.

J. Sonke, E. Damen, J. Belderbos, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Local and regional treatment response by 18FDG-PET-CT-scans 4 weeks after concurrent hypofractionated chemoradiotherapy in locally advanced NSCLC.

J. Sonke, J. Belderbos, E. van Werkhoven, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

In response to Park, et al.

J. Sonke, J. Belderbos, M. Kwint, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A secondary analysis of FDG spatio-temporal consistency in the randomized phase II PET-boost trial in stage II-III NSCLC.

J. Sonke, W. V. van Elmpt, D. de Ruysscher, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy dose and fractionation for stage III NSCLC.

D. de Ruysscher, M. Verheij, J. Belderbos, 2015, The Lancet. Oncology.

The role of surgery for stage I non-small cell lung cancer in octogenarians in the era of stereotactic body radiotherapy in the Netherlands.

R. Damhuis, K. Hartemink, J. Daniels, 2020, Lung cancer.

A Prospective Study: Current Problems in Radiotherapy for Nasopharyngeal Carcinoma in Yogyakarta, Indonesia

I. Tan, I. B. Tan, R. Fles, 2014, PloS one.

5-Oxoproline as a cause of high anion gap metabolic acidosis: an uncommon cause with common risk factors.

P. Nanayakkara, M. V. van Agtmael, C. Jakobs, 2008, The Netherlands journal of medicine.

Results of neoadjuvant chemo(radio)therapy and resection for stage IIIA non-small cell lung cancer in The Netherlands

E. Smit, H. Klomp, J. Belderbos, 2020, Acta oncologica.

Heart dose associated with overall survival in locally advanced NSCLC patients treated with hypofractionated chemoradiotherapy.

J. Sonke, E. Damen, J. Belderbos, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.